[1] 王瑾, 郑荣生. 乙醛脱氢酶1和转化生长因子β2在乳腺癌组织中的表达及意义[J].肿瘤防治研究, 2013, 40(11):1054-1058. [2] 郭变琴, 吴立翔, 汪先桃,等. Wnt2在乳腺癌组织及患者血清中的表达及意义[J].细胞与分子免疫学杂志, 2013, 29(6):633-636. [3] 刘佩姿, 黄犁, 江亮,等. 钙结合蛋白S100A4和zeste基因增强子同源物2在乳腺癌组织中的表达及临床意义[J].中华实验外科杂志, 2015, 32(7):1669-1671. [4] 张慧宇, 魏燕, 高剑波,等. 二脂酰甘油酰基转移酶在乳腺癌组织的表达及其临床意义[J].中华实验外科杂志, 2016, 33(4):936-938. [5] Sultana T, Rahman AJ. Cytological grading of duct cell carcinoma, NOS of breast and its correlation with histological grading[J].Bangladesh Med Res Counc Bull,2006, 32(2):49-54. [6] 刘秀娟, 高静, 姜英翰,等. 乳腺癌NOEY2基因启动子区甲基化的研究[J].解放军医药杂志, 2015,27(4):7-11. [7] 方德刚. VEGF、MVD、nm-23在人乳腺癌变组织中的表达及其意义[J].医学临床研究, 2011, 28(9):1691-1692. [8] Wu X, Liang L, Dong L,et al. Effect of ARHI on lung cancer cell proliferation, apoptosis and invasion in vitro[J].Mol Biol Rep,2013, 40(3):2671-2678. [9] 张清, 马德奎, 谭敏华,等. 抑癌基因PTEN在原发性乳腺浸润性导管癌中的表达及临床意义[J].中国现代医学杂志, 2012, 22(35):47-50. [10] Zuo X, Qin Y, Zhang X, et al. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI [J].Oncol Rep,2014, 31(5):2358-2364. [11] Li J, Cui G, Sun L, et al. STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer. [J].Oncol Rep,2013, 30(1):165.
2018, Vol. 35 
